261/314US=23-C / Câncer
Owens SR. Anal squamous cell carcinomas: diagnosis using p63 immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 463-70. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; CANCER DE ANUS; CARCINOMAS ESCAMOSOS DE CELULAS ANAL; DIAGNOSTICO; IMUNOHISTOQUIMICA; P63


262/314US=23-C / Câncer
Quah HM, Weiser MR. Molecular and clinicopathologic features which predict outcome in patients with anorectal melanoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 471-83. ISBN 978-1-4020-9544-3.

CANCER COLORRETAL; CANCER DE ANUS; MELANOMA ANORRETAL; CARACTERISTICAS MOLECULARES; CARACTERISTICAS CLINICOPATOLOGICAS; TRATAMENTO; PROGNOSTICO


263/314Câncer
Wainstein AJA, Kansaon MJM, Siqueira RR, Conceição SA, Lacerda LT, Oliveira BRR, Santos FAV. Primary anorectal melanoma: report of 4 cases and literature review (case report). Applied Cancer Research, São Paulo: Tecmedd, v.31, n.4, p. 146-50, 2011. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.146-50.pdf

NEOPLASIA DE ANUS; MELANOMA; NEOPLASIA RETAL


264/314US=42 / Gastro
Rau BM. Clinical assessment and biochemical markers to objectify severity and prognosis. In: Beger H, Warshaw A, Büchler M, Kozarek RA, Lerch MM, Neoptolemos JP, Shiratori K, Whitcomb DC, Rau BM. The pancreas: an integrated textbook of basic science, medicine, and surgery. 2nd ed. Massachuetts: Blackwell Scientific Publications, 2008. p. 242-54. ISBN 978-1-4051-4664-7.

PANCREATITE AGUDA. AVALIACAO CLINICA; PANCREATITE AGUDA. PROGNOSTICO; MARCADORES BIOQUIMICOS; PANCREATITE AGUDA. FATORES DE RISCO


265/314US=44 / Gastro
Lovell M, Bhan C, Jankowski J, McDonald S. Molecular biology of gastroesophageal cancers: the role of mutational analysis in prognosis. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 21-30. ISBN 978-1-4051-2783-7.

CANCER GASTROESOFAGICO; CANCER GASTRICO. BIOLOGIA MOLECULAR; ANALISE MUTACIONAL NO PROGNOSTICO; CANCER ESOFAGICO. BIOLOGIA MOLECULAR; CARCINOMA DE CELULAS ESCAMOSAS ESOFAGICAS; ADENOCARCINOMA ESOFAGICO


266/314US=44 / Gastro
Wang KK. Esophageal adenocarcinoma: prognosis and follow-up. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 98-113. ISBN 978-1-4051-2783-7.

ADENOCARCINOMA ESOFAGICO. PROGNOSTICO


267/314US=104 / Câncer
Mackillop WJ. Principles of prognostic factor: the importance of prognosis in cancer medicne. In: Gospodarowicz MK, Sullivan BO, Sobin LH. Prognostic factors in cancer. New Jersey: John Wiley & Sons, 2006. p. 3-22. (International Union Against Cancer) ISBN 978-0-470-03801-2.

FATOR PROGNOSTICO; PROGNOSTICO NO CANCER; PROGNOSTICO EM ONCOLOGIA


268/314US=104 / Câncer
Liu GG, Zhou W, Wang Z, McLeod HL. Principles of prognostic factor: incorporating molecular oncology into prognosis. In: Gospodarowicz MK, Sullivan BO, Sobin LH. Prognostic factors in cancer. New Jersey: John Wiley & Sons, 2006. p. 79-94. (International Union Against Cancer) ISBN 978-0-470-03801-2.

FATOR PROGNOSTICO; ONCOLOGIA MOLECULAR. PROGNOSTICO; PROGNOSTICO DO CANCER; POLIMORFISMOS GENETICOS


269/314US=88 / Biol/Mol
McBrian MA, Seligson DB, Kurdistani SK. Histone modifications in cancer biology and prognosis. In: Tollefsbol T. Cancer epigenetics. Boca Raton: CRC, 2009. p. 359-79. ISBN 978-1-4200-4579-6.

CANCER; EPIGENETICA; CANCER. PROGNOSTICO; MODIFICACOES DAS HISTONAS; ACETILACAO DA HISTONA; METILACAO DA HISTONA


270/314US=2 / Mama
De Bortoli M, Biglia N. Assays for gene expression and post-translational protein abnormalities: gene expression profiling with DNA microarrays: revolutionary tools to help diagnosis, prognosis, treatment guidance, and drug discovery. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 47-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4.

CANCER DE MAMA; ENSAIOS DA EXPRESSAO DO GENE; ANORMALIDADES POS-TRADUCIONAIS; PERFIL DE EXPRESSAO GENICA; MICROARRANJOS DE DNA


271/314US=30 / Pelvis
Greeno EW. Understanding your prognosis. In: Levin B, Ades T, Brooks D, Crane CH, Hoff PM, Limburg PJ, Rothenberger DA. Complete guide to colorectal cancer. Atlanta: American Cancer Society, 2006. p. 89-97. ISBN 9787-0944235-55-7.

CANCER COLORRETAL. PROGNOSTICO; SOBREVIVENCIA


272/314US=47 / Clín/Medica
Berrino F, Villarini A, Petris M, Raimondi M, Pasanisi P. Adjuvant diet to improve hormonal and metabolic factors affecting breast cancer prognosis. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 110-8. ISBN 978-1-57331-699-5.

CANCER DE MAMA; HORNOMAL; FATORES METABOLICOS; DIETA


273/314US=14 / Urologia
Kondagunta GV, Bosl GJ, Motzer RJ. Testis cancer: management and treatment of foor prognosis and relapsed germ cell tumors. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 645-54. ISBN 978-0-7817-4984-0.

CANCER DE TESTICULO; TRATAMENTO DE PROGNOSTICO; TUMORES DE CELULAS GERMINATIVAS


274/314Câncer
Ramos AP, Marques GIG, Mendonça YA, Dourado JC, Soares RBA. Clinical evaluation of normal tissue toxicity induced by ionizing radiation in cases of laryngeal carcinoma. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.3, p. 60-3, 2012. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(3)p.60-3.pdf

EFEITOS ADVERSOS; CANCER DE LARINGE; TOXICIDADE; RADIOTERAPIA


275/314Câncer
Carvalho ALH, Hildebrand LC, Haas AN, Lauxen IS, Sant’Ana Filho M. Head and neck squamous cell carcinoma: decline in clinical stage at the time of diagnosis in a reference hospital in Southern Brazil. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.4, p. 111-5, 2012. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(4)p.111-5.pdf

CARCINOMA; DIAGNOSTICO; CANCER DE CABECA E PESCOCO; CELULAS ESCAMOSAS. CARCINOMA


276/314US=16 / Ortopedia
Plunkett TS, Rubens RD. Clinical features and assessment: clinical features and prognosis of bone metastases. In: Jasmin C, Coleman RE, Coia LR, Capanna R, Saillan G. Textbook of bone metastases. New Jersey: John Wiley & Sons, 2005. p. 65-75. ISBN 978-0-471-87742-5.

METASTASE NEOPLASICA. DIAGNOSTICO; NEOPLASIAS DA PROSTATA; MIELOMA MULTIPLO; PROGNOSTICO


277/314US=16 / Tórax
Wozniak AJ, Gadgeel SM. Clinical presentation, diagnosis, staging, and prognosis: clinical presentation of non-small cell carcinoma of the lung. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 291-303. ISBN 0-7817-4620-5.

CARCINOMA DE CELULAS NAO PEQUENAS DO PULMAO; MANIFESTACAO NO LOCAL DA DOENCA; MANIFESTACOES AVANCADA DA DOENCA; MANIFESTACAO EXTRATORACICA; MANIFESTACAO MUCOCUTANEAS; SINDROMES HEMATOLOGICAS; MANIFESTACAO VASCULAR


278/314US=16 / Tórax
Masters GA. Clinical presentation, diagnosis, staging, and prognosis: clinical presentation of small cell lung cancer. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 304-14. ISBN 0-7817-4620-5.

CARCINOMA DE CELULAS PEQUENAS; SINAIS E SINTOMAS; METASTASE REGIONAL; METASTASE SISTEMICA; EXAMINACAO CLINICA; SINDROMES PARANEOPLASICAS


279/314US=16 / Tórax
Quint LE, Francis IR, Gross BH. Clinical presentation, diagnosis, staging, and prognosis: conventional imaging of non-small cell lung cancer. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 315-44. ISBN 0-7817-4620-5.

CARCINOMA BRONCOGENICO; DIAGNOSTICO RADIOLOGICO; NODULO PULMONAR SOLITARIO; TUMOR PRIMARIO; ESTAGIO DA NEOPLASIA PULMONAR; TUMOGRAFIA COMPUTARIZADA; RESSONANCIA MAGNETICA


280/314US=16 / Tórax
Vansteenkiste JF, Hoekstra OS, Stroobants SG, Smit EF, Postmus PE. Clinical presentation, diagnosis, staging, and prognosis: pet in lung cancer. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 345-57. ISBN 0-7817-4620-5.

NEOPLASIAS PULMONAR; TOMOGRAFIA POR EMISSAO DE POSITRON; NODULOS PULMONARES. DIAGNOSTICO; TRATAMENTO; SOBREVIDA; PROGNOSTICO


Primeira | Anterior | Próxima | Última